There is very little discussion of the effects the law suits are having on Geron's willingness to say much more than the bare, legal minimum required to keep investors informed. Do the lawsuits have merit? Personally, I don't think so, but they nevertheless must be considered in just about everything the company and its management do in the public arena. It remains my hope that we will soon see the FDA hold released and, as a result, the lawsuits rendered harmless. But until that happens, we shouldn't expect anything from the company that might add to OUR problems. Isn't that responsible management?
Good post, and thanks. Our government has been under attack ever since these words were uttered, "Government is the problem, not the solution." Few people have asked themselves: What, or who, benefits the most by this attack on our government? The answer: The businesses and corporations who are (were?) regulated by it. Only a few years ago, we saw once more in out country's history what the excesses of doing business purely for the sake of profit leads to. Like it or not, government oversight and regulation is essential to a free market economy. We should only require that it operates fairly, effectively, in the larger public interest, not in the individual corporate interest, as has happened all too often since those famous words were spoken. If we have a problem with our government, and we do, it is the fact that it is lobbied to death, literally! We need to look at the elected people as a problem in that respect, not the professionals located within the agencies. They too are the victims of what has been going on.
Yes, it is the advisory boards that should be looked at, but this damnable congress can't look at anything with an objective eye!!
There remains the possibility, and even likelihood, that news the market was not anticipating will suddenly come. If the market begins to see the broader potential of imetelstat in treating cancer, coupled with FDA action dismissing concerns over toxicity, the results could be absolutely explosive to the upside, well beyond what has been talked about on this board. As I have been saying, when the news comes that we need, it will not have been anticipated. I still believe that.
The games will only begin when (hopefully, not if) the FDA lifts the hold. And, if special status were granted based on efficacy against a heretofore incurable and deadly disease, then there will be no need to compare GERN with INCY, at all. The game will be ours alone.
Concerning today's post that the company still owns GRN510, exactly what is its status? Does anyone know. I'm afraid it's been off my radar screen so long that I've lost sight of it.
Valuation is key to a buy out, I agree, and we're not even close to being able to determine that now. A partnership, however, based on evidence and data already available, might be plausible. What I would be concerned about under a partnership arrangement is what entitlements would be granted the partner pursuant to an FDA clearance. Geron and its stock holders deserve to optimize the reward for going through all this time, turmoil and uncertainty. Speaking for myself, let's not be too anxious for either a partnership or a buyout until we have more information concerning the future potential of Imetelstat in cancer treatment, including beyond hematological types.
My mistake. Someone questioned that number and suggested that it would be no more than 10. Don't know where that post was, but that's what I was referring to.
Congress can't find its arse with both hands, let alone do something of value and substance. But yes, that's exactly how to solve the problem - transaction fee and/or short-short -term capital gain tax. The stock market long ago departed from its original design and purpose. Once financial institutions and markets themselves become part of the money making enterprise, as did the investment banks leading up to the collapse a few years ago, we are one step away from big trouble. We've become a nation driven by the idea of making money for money's sake, rather than what money can do for the good of the larger society, and our institutions have become corrupted by the same thinking.
Yep, looks like there could be REAl strength beginning to build and, as others have posted in recent days, this time, there may be real reasons to sustain that strength. Sure would be nice to end this year, for a change, sitting pretty. As always, time will tell.
You REALLY should try to get out more, and away from this board. Leave you i-phone at home. Go have fun. Think positive. Or, are your playing the part of the broken record because you enjoy all those thumbs down you keep getting? Don't answer. I've lost my interest.
More than anything else that has been said on this board, what you have just posted clearly speaks to why the FDA made the exception for Mayo. Understandably, at least to me, that doesn't absolve Geron of the responsibility to furnish the additional data needed to remove the hold in total, but it may help to explain why the bar (according to Scarlet) has been set relatively "low." Everything points to the hold being resolved in our favor, but it remains very important that Geron take the time to do a good job in developing the required data. If it were insufficient for purposes of the FDA, a rejection could be our demise, once and for all. Speaking for myself, take the time necessary to do the job right. As usual, thanks much for your input.